Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
Guo Chen1, Dongkyoo Park1, Andrew T Magis2
1Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia.
Cancer Research
|October 31, 2019
Summary
Scientists found that Mcl-1 protein activates Akt kinase, promoting lung cancer growth. Inhibiting this Mcl-1/Akt interaction with a new molecule, PH-687, suppressed tumor growth, offering a novel lung cancer treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mcl-1 is an antiapoptotic protein crucial for cancer cell survival.
- Akt is an oncogenic kinase with elevated activity in many human cancers.
- Understanding Mcl-1 and Akt interactions is key to developing new cancer therapies.
Purpose of the Study:
- To investigate the cross-talk between Mcl-1 and Akt in lung cancer.
- To identify mechanisms by which Mcl-1 influences Akt activity.
- To develop novel therapeutic strategies targeting the Mcl-1/Akt interaction.
Main Methods:
- CRISPR/Cas9 and shRNA were used to deplete Mcl-1 in lung cancer cells.
- Co-immunoprecipitation was employed to study Mcl-1 and Akt interaction.
- A novel small molecule, PH-687, was identified and tested for its efficacy.
- In vitro and in vivo models (xenografts) were used to assess therapeutic effects.
Main Results:
- Mcl-1 depletion significantly decreased Akt activity and suppressed lung cancer cell growth.
- Mcl-1 directly binds to Akt's PH domain, disrupting intramolecular interactions and activating Akt.
- Mcl-1 expression positively correlated with Akt activity in non-small cell lung cancer tissues.
- PH-687 effectively disrupted Mcl-1/Akt binding, inhibited Akt activity, and reduced tumor growth.
Conclusions:
- Mcl-1 acts as a crucial activator of Akt in lung cancer.
- Targeting the Mcl-1/Akt interaction is a promising therapeutic strategy for lung cancer.
- The small molecule PH-687 demonstrates potential as a novel lung cancer treatment.
More Related Videos
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
01:19Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
02:38Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K